Ironwood Pharmaceuticals files patent for delayed release pharmaceutical composition containing linaclotide

Discover Ironwood Pharmaceuticals' innovative patent for delayed release pharmaceutical compositions with linaclotide. Learn about the unique design and targeted therapeutic effects for gastrointestinal disorders.

Mar 24, 2024 - 00:00

Discover Ironwood Pharmaceuticals' innovative patent for delayed release pharmaceutical compositions with linaclotide. Learn about the unique design and targeted therapeutic effects for gastrointestinal disorders.

Read the original article

Tags:

Previous Article

AnGes files patent for crispr-based method for modifying mutant lRRK2 gene in cells

2 in 3 parents say their adolescent or teen worries about how sick days may impa...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Menarini signs agreement for Astellas’s rheumatoid arthritis therapy

Menarini signs agreement for Astellas’s rheumatoid arth...

Sep 13, 2023

STAT+: Antitrust lawsuit alleges UnitedHealth’s Optum pressured a California hospital to stop competing over physicians

STAT+: Antitrust lawsuit alleges UnitedHealth’s Optum p...

Nov 25, 2023

STAT+: Mark Cuban’s drug company creates a pharmacy network to challenge PBMs

STAT+: Mark Cuban’s drug company creates a pharmacy net...

Apr 19, 2023